This is a firm fixed price purchase order awarded by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH), to University College London (UCL) for $77,000.00. The contract does not have a set-aside designation. Under this purchase order, UCL will provide products or services in support of NIDA's biomedical research mission. UCL is a leading international university based in the United Kingdom that has received numerous prime federal contract awards...
This $345,500 firm fixed price purchase order was awarded by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH), to the University College London (UCL) on January 12, 2024. The contract does not have a set-aside designation. UCL, a leading international research university based in London, United Kingdom, will provide unspecified products or services to support NIDA's biomedical research mission. UCL has collaborated extensively with U.S....
The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a $419,000.00 firm-fixed-price purchase order contract to the University College London (UCL) to provide tuition payments. The contract has a completion date of September 30, 2023 and was awarded on October 2, 2020. UCL is a leading multidisciplinary university in the United Kingdom that has previously received federal contract and grant awards from the Department of Health and...
This is a $77,274 firm fixed price purchase order awarded by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH), to University College London (UCL) on September 22, 2017. The contract has an ultimate completion date of June 24, 2018 and does not have a set-aside designation. UCL is a leading international university based in the United Kingdom that provides research and educational services to U.S. federal agencies. This contract award supports...
This federal contract award to Eurofins Discoverx Corporation, a foreign-owned for-profit organization, was issued by the National Institute on Drug Abuse (NIDA), a component of the U.S. Department of Health and Human Services. The $26,769.20 firm fixed-price purchase order is for the provision of PathHunter detection kit reagent, item #93-0001L, to support the HEAL (Helping to End Addiction Long-term) initiative's medicinal chemistry research to improve potency and selectivity of dopamine...
<p>The National Institute on Drug Abuse (NIDA), a civilian agency, awarded a $183,731.46 firm-fixed-price purchase order contract to Oxford Stemtech LTD for scientific support services related to the generation and multiomics profiling of induced pluripotent stem cell-derived neuronal models. The contract does not have a set-aside designation, and the ultimate completion date is September 10, 2025. This contract award is not associated with a larger acquisition vehicle.</p>
This is a firm fixed-price purchase order issued by the National Cancer Institute (NCI), a civilian agency of the U.S. government, to Drexel University, a private research university, for a FELLOWSHIP PROGRAM FEE. The award is valued at $16,400.00 with a performance period ending on June 30, 2025. The contract does not have a set-aside designation. Drexel University has a long history of serving as both a prime contractor and subcontractor on research and development initiatives funded by...
This federal contract award, with a ceiling value of $1,927,163.66, was issued by the National Institute on Drug Abuse (NIDA), a component of the U.S. Department of Health and Human Services. The contract was awarded to SRI International, a non-profit research and development organization, and is part of NIDA's Pharmacology and Toxicology for Neurotherapeutics Program (PTNP). The contract, which is a Delivery Order under the PTNP Indefinite Delivery Vehicle (IDV), is for IND-enabling studies....
This federal contract award was issued by the National Institute on Drug Abuse, a civilian agency within the Department of Health and Human Services, to Palladian Partners, Inc., a subsidiary of the Altarum Institute. The $93,662.80 delivery order is for transcription and meeting support services for the Combined Neurosciences Institutional Review Board of the National Institute of Neurological Disorders and Stroke. The contract is part of the NIH Conference Administrative and Travel Services II...
This is a $49,998.42 firm fixed-price purchase order contract awarded by the National Institute on Drug Abuse, a civilian federal agency, to Bar-Haim Yair, a non-profit organization located in Rockville, Maryland. The contract has an ultimate completion date of June 4, 2025 and was awarded on July 3, 2023. The contract does not have a set-aside designation. Based on the agency, this contract is likely related to the National Institute on Drug Abuse's research and programmatic initiatives focused...